Outcomes of combination therapy with nusinersen, onasemnogene abeparvovec, and risdiplam over 3.5 years in a patient with prenatally diagnosed spinal muscular atrophy type 0: A case report. - Okubo Y; Togashi N; Morishita Y; Yoshida S; Kawaji T; Kawashima A; Katata Y; Uneoka S; Yagi Y; Endo W; Inui T; Kato T; et al. (Brain & development, 2026)